Curaleaf International Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
446
- Latest Deal Type
-
2ndary - Private
Curaleaf International General Information
Description
Developer of plant-derived therapeutics designed for medical applications. The company is engaged in the cultivation, extraction, production, and distribution of medical cannabis products, enabling the healthcare community to treat patients suffering from chronic pain, spasticity, and cancer.
Contact Information
Website
www.curaleafinternational.com(Operating Subsidiary)
Corporate Office
- Hill Dickinson Llp The Broadgate Tower
- 20 Primrose Street
- London EC2A 2EW
- England, United Kingdom
Corporate Office
- Hill Dickinson Llp The Broadgate Tower
- 20 Primrose Street
- London EC2A 2EW
- England, United Kingdom
Curaleaf International Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | 08-Jul-2025 | Completed | Generating Revenue | |||
| 8. Early Stage VC | 07-Apr-2021 | Completed | Generating Revenue | |||
| 7. Merger/Acquisition | 07-Apr-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 04-Mar-2021 | Completed | Generating Revenue | |||
| 5. Reverse Merger | 24-Jul-2020 | Cancelled | Generating Revenue | |||
| 4. Early Stage VC | 31-Jan-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 16-Oct-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 18-Sep-2019 | $12.3M | $34.5M | Completed | Generating Revenue | |
| 1. Early Stage VC | 14-Mar-2019 | $22.2M | $22.2M | Completed | Generating Revenue |
Curaleaf International Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Curaleaf International Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Curaleaf International Patents
Curaleaf International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202510110-D0 | Formulation | Inactive | 24-Jun-2025 | ||
| GB-202411714-D0 | Formulation | Inactive | 08-Aug-2024 | ||
| WO-2026033228-A1 | Formulation | Pending | 08-Aug-2024 | ||
| EP-4262755-A1 | Topical pharmaceutical formulation and method for the treatment of syndromes associated with chronic pelvic pain | Pending | 18-Dec-2020 | ||
| US-20240033213-A1 | Topical pharmaceutical formulation and method for the treatment of syndromes associated with chronic pelvic pain | Pending | 18-Dec-2020 | A61K9/0014 |
Curaleaf International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Curaleaf International Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Altitude Investment Management | Venture Capital | Minority | ||
| Bloom Ventures | Venture Capital | Minority | ||
| Enexis (Sweden) | Venture Capital | Minority | ||
| Gestio Capital | Family Office | Minority | ||
| Material V | Venture Capital | Minority |
Curaleaf International Investments & Acquisitions (9)
Curaleaf International’s most recent deal was a Merger/Acquisition with Curaleaf Medical Center. The deal was made on 01-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Curaleaf Medical Center | 01-Apr-2025 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Can4Med | 02-Feb-2024 | Merger/Acquisition | Distributors/Wholesale | ||
| Curaleaf Clinic | 31-Jan-2022 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Terra Verde (Portugal) | 16-Jul-2019 | Merger/Acquisition | Cultivation | ||
| Fontana JVCo | 09-Jul-2019 | Joint Venture | Other Consumer Non-Durables |
Curaleaf International Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Curaleaf Medical Center | Warsaw, Poland | 2020 | |
| Curaleaf Clinic | Sunderland, United Kingdom | 2019 | |
| Rokshaw Laboratories | Sunderland, United Kingdom | 2012 | |
| Medalchemy | Alicante, Spain | 2002 |
Curaleaf International FAQs
-
When was Curaleaf International founded?
Curaleaf International was founded in 2018.
-
Where is Curaleaf International headquartered?
Curaleaf International is headquartered in London, United Kingdom.
-
What is the size of Curaleaf International?
Curaleaf International has 446 total employees.
-
What industry is Curaleaf International in?
Curaleaf International’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Curaleaf International a private or public company?
Curaleaf International is a Private company.
-
What is Curaleaf International’s current revenue?
The current revenue for Curaleaf International is .
-
How much funding has Curaleaf International raised over time?
Curaleaf International has raised $130M.
-
Who are Curaleaf International’s investors?
Altitude Investment Management, Bloom Ventures, Enexis (Sweden), Gestio Capital, and Material V are 5 of 7 investors who have invested in Curaleaf International.
-
When was Curaleaf International acquired?
Curaleaf International was acquired on 08-Jul-2025.
-
Who acquired Curaleaf International?
Curaleaf International was acquired by Curaleaf Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
